Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?

• Published in: Journal of microbiology, immunology and infection Vol. 53; no. 4; pp. 505 - 512
• Main Authors: Lai, Chih-Cheng, Wang, Cheng-Yi, Hsueh, Po-Ren
• Format: Journal Article
• Language: English
• Published: England Elsevier B.V 01.08.2020; Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC; Elsevier
• Subjects: Anti-Infective Agents - therapeutic use; Betacoronavirus - isolation & purification; Clinical Laboratory Techniques; Co-infection; Coinfection - diagnosis; Coinfection - drug therapy; Coinfection - epidemiology; Coronavirus Infections - diagnosis; Coronavirus Infections - drug therapy; Coronavirus Infections - epidemiology; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Drug Therapy, Combination; Humans; Influenza viruses; Pandemics; Pneumonia, Viral - diagnosis; Pneumonia, Viral - drug therapy; Pneumonia, Viral - epidemiology; Practice Guidelines as Topic; Reagent Kits, Diagnostic; SARS-CoV-2; COVID-19; Influenza viruses; SARS-CoV-2; Co-infection

Co-infection has been reported in patients with severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome, but there is limited knowledge on co-infection among patients with coronavirus disease 2019 (COVID-19). The prevalence of co-infection was variable among COVID-19 patients i...